CD14 and pancreatic ductal adenocarcinoma: PD-L1 was enhanced in c-FLIP-expressing CD14+ cells (Supplementary information, Fig. S1F), in agreement with our previous findings in pancreatic ductal adenocarcinoma (PDAC) patients [35], hinting to common mechanisms of innate immunity modulation in COVID-19 and cancer.